Viewing Study NCT04124094


Ignite Creation Date: 2025-12-25 @ 1:41 AM
Ignite Modification Date: 2026-01-22 @ 9:15 AM
Study NCT ID: NCT04124094
Status: COMPLETED
Last Update Posted: 2020-07-07
First Post: 2019-10-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Bioequivalence Study Between Fluticasone and Salmeterol vs. SERETIDE DISKUSĀ® in Healthy Volunteers With Charcoal Blockade
Sponsor: Respirent Pharmaceuticals Co Ltd.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2019-10-01
Start Date Type: ACTUAL
Primary Completion Date: 2019-10-25
Primary Completion Date Type: ACTUAL
Completion Date: 2020-06-09
Completion Date Type: ACTUAL
First Submit Date: 2019-10-08
First Submit QC Date: None
Study First Post Date: 2019-10-11
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-07-05
Last Update Post Date: 2020-07-07
Last Update Post Date Type: ACTUAL